These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
236 related articles for article (PubMed ID: 24794314)
21. Anti-Müllerian hormone versus antral follicle count for defining the starting dose of FSH. Lan VT; Linh NK; Tuong HM; Wong PC; Howles CM Reprod Biomed Online; 2013 Oct; 27(4):390-9. PubMed ID: 23953069 [TBL] [Abstract][Full Text] [Related]
22. Correlation of antimüllerian hormone and baseline follicle-stimulating hormone levels. Singer T; Barad DH; Weghofer A; Gleicher N Fertil Steril; 2009 Jun; 91(6):2616-9. PubMed ID: 18555223 [TBL] [Abstract][Full Text] [Related]
23. Correlation of age and antimullerian hormone in assisted reproductive technology program outcome. Himabindu Y; Gopinathan KK; Pandey AK; Sriharibabu M Indian J Physiol Pharmacol; 2013; 57(1):9-15. PubMed ID: 24020093 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Kwee J; Schats R; McDonnell J; Themmen A; de Jong F; Lambalk C Fertil Steril; 2008 Sep; 90(3):737-43. PubMed ID: 17923131 [TBL] [Abstract][Full Text] [Related]
25. Ovarian reserve assessment in users of oral contraception seeking fertility advice on their reproductive lifespan. Birch Petersen K; Hvidman HW; Forman JL; Pinborg A; Larsen EC; Macklon KT; Sylvest R; Andersen AN Hum Reprod; 2015 Oct; 30(10):2364-75. PubMed ID: 26311148 [TBL] [Abstract][Full Text] [Related]
26. Age-specific serum antimüllerian hormone levels in women with and without polycystic ovary syndrome. Cui Y; Shi Y; Cui L; Han T; Gao X; Chen ZJ Fertil Steril; 2014 Jul; 102(1):230-236.e2. PubMed ID: 24746743 [TBL] [Abstract][Full Text] [Related]
27. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol. Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354 [TBL] [Abstract][Full Text] [Related]
29. Age at menarche: a predictor of diminished ovarian function? Weghofer A; Kim A; Barad DH; Gleicher N Fertil Steril; 2013 Oct; 100(4):1039-43. PubMed ID: 23809497 [TBL] [Abstract][Full Text] [Related]
30. Multicenter evaluation of the Access AMH antimüllerian hormone assay for the prediction of antral follicle count and poor ovarian response to controlled ovarian stimulation. Baker VL; Gracia C; Glassner MJ; Schnell VL; Doody K; Coddington CC; Shin SS; Marshall LA; Alper MM; Morales AJ; Pavone ME; Behera MA; Zbella EA; Shapiro BS; Straseski JA; Broyles DL Fertil Steril; 2018 Aug; 110(3):506-513.e3. PubMed ID: 29960708 [TBL] [Abstract][Full Text] [Related]
31. Systemic methotrexate to treat ectopic pregnancy does not affect ovarian reserve. Oriol B; Barrio A; Pacheco A; Serna J; Zuzuarregui JL; Garcia-Velasco JA Fertil Steril; 2008 Nov; 90(5):1579-82. PubMed ID: 18054933 [TBL] [Abstract][Full Text] [Related]
32. Does obesity compromise ovarian reserve markers? A clinician's perspective. Malhotra N; Bahadur A; Singh N; Kalaivani M; Mittal S Arch Gynecol Obstet; 2013 Jan; 287(1):161-6. PubMed ID: 22930149 [TBL] [Abstract][Full Text] [Related]
33. Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. van Rooij IA; Broekmans FJ; Scheffer GJ; Looman CW; Habbema JD; de Jong FH; Fauser BJ; Themmen AP; te Velde ER Fertil Steril; 2005 Apr; 83(4):979-87. PubMed ID: 15820810 [TBL] [Abstract][Full Text] [Related]
34. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos. Majumder K; Gelbaya TA; Laing I; Nardo LG Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579 [TBL] [Abstract][Full Text] [Related]
35. Comparison of markers of ovarian reserve between patients with complete müllerian agenesis and age-matched fertile and infertile controls. Ozekinci M; Erman Akar M; Senol Y; Ozdem S; Uzun G; Daloglu A; Ongut G Fertil Steril; 2015 Jul; 104(1):176-9. PubMed ID: 26025811 [TBL] [Abstract][Full Text] [Related]
36. Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fiçicioglu C; Kutlu T; Baglam E; Bakacak Z Fertil Steril; 2006 Mar; 85(3):592-6. PubMed ID: 16500324 [TBL] [Abstract][Full Text] [Related]
37. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection. Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376 [TBL] [Abstract][Full Text] [Related]
38. Antimüllerian hormone as predictor of reproductive outcome in subfertile women with elevated basal follicle-stimulating hormone levels: a follow-up study. Yarde F; Voorhuis M; Dólleman M; Knauff EA; Eijkemans MJ; Broekmans FJ Fertil Steril; 2013 Sep; 100(3):831-8. PubMed ID: 23755952 [TBL] [Abstract][Full Text] [Related]
39. Antimüllerian hormone as a measure of reproductive function in female childhood cancer survivors. Lunsford AJ; Whelan K; McCormick K; McLaren JF Fertil Steril; 2014 Jan; 101(1):227-31. PubMed ID: 24083876 [TBL] [Abstract][Full Text] [Related]
40. Characterization of women with elevated antimüllerian hormone levels (AMH): correlation of AMH with polycystic ovarian syndrome phenotypes and assisted reproductive technology outcomes. Tal R; Seifer DB; Khanimov M; Malter HE; Grazi RV; Leader B Am J Obstet Gynecol; 2014 Jul; 211(1):59.e1-8. PubMed ID: 24593938 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]